<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Charrière, Nathalie</dc:creator>
  <dc:creator>Loonam, Cathriona</dc:creator>
  <dc:creator>Montani, Jean-Pierre</dc:creator>
  <dc:creator>Dulloo, Abdul G.</dc:creator>
  <dc:creator>Grasser, Erik Konrad</dc:creator>
  <dc:date>2017-09-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">PurposeThere is increasing interest into the potentially beneficial effects of galactose  for obesity and type 2 diabetes management as it is a low-glycemic sugar reported to  increase satiety and fat mobilization. However, fructose is also a low-glycemic sugar  but with greater blood pressure elevation effects than after glucose ingestion.  Therefore, we investigated here the extent to which the ingestion of galactose,  compared to glucose and fructose, impacts upon haemodynamics and blood  pressure.MethodsIn a randomized cross-over study design, 9 overnight-fasted young  men attended 3 separate morning sessions during which continuous cardiovascular  monitoring was performed at rest for at least 30 min before and 120 min after  ingestion of 500 mL of water containing 60 g of either glucose, fructose or galactose.  These measurements included beat-to-beat systolic and diastolic blood pressure,  heart rate deduced by electrocardiography, and stroke volume derived by impedance  cardiography; these measurements were used to calculate cardiac output and total  peripheral resistance.ResultsIngestion of galactose, like glucose, led to significantly  lesser increases in systolic, diastolic and mean blood pressure than fructose ingestion  (p &lt; 0.05). Furthermore, the increase in cardiac output and reduction in total  peripheral resistance observed after ingestion of glucose were markedly lower after  galactose ingestion (p &lt; 0.01).ConclusionsGalactose thus presents the interesting  characteristics of a low-glycemic sugar with mild cardiovascular effects. Further  studies are warranted to confirm the clinical relevance of the milder cardiovascular  effects of galactose than other sugars for insulin resistant obese and/or diabetic  patients with cardiac insufficiency.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/305997</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/305997/files/dull_crs.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1007/s00394-016-1250-9</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>European Journal of Nutrition. - 2017, vol. 56, no. 6, p. 2105–2113</dc:source>
  <dc:subject>info:eu-repo/classification/udc/613.2</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Cardiovascular responses to sugary drinks in humans: galactose presents milder cardiac effects than glucose or fructose</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
